Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Oguchi disease in which the cause of the disease is a mutation in the SAG gene.
Features include always present findings: Congenital stationary night blindness and Mizuo phenomenon.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Congenital stationary night blindness |
Pregnancy and birth |
SAG function has not been fully characterized.
Oguchi disease-1 is associated with mutations in the SAG gene on chromosome 2.
Genetic testing for SAG is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Oguchi disease-1 has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for Oguchi disease-1.
15 publications have been identified in PubMed for Oguchi disease-1. Research spans Case Report / Case Series (53%), Review / Meta-Analysis (13%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 53% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:43 AM UTC
Online Mendelian Inheritance in Man
Common questions about Oguchi disease-1
1
Congenital stationary night blindness |
2 |
13% |
Laboratory research | 2 | 13% |
Testing and diagnosis research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
New treatment approaches | 1 | 7% |
Tekin K (2026). [PMID: 42162247](https://pubmed.ncbi.nlm.nih.gov/42162247/). *Eye (Lond)*. [Case Report / Case Series]
Fathy N (2026). [PMID: 41520369](https://pubmed.ncbi.nlm.nih.gov/41520369/). *Ophthalmic Genet*. [Gene Therapy / Novel Therapeutics]
Mariscal J (2026). [PMID: 41110996](https://pubmed.ncbi.nlm.nih.gov/41110996/). *Ophthalmic Genet*. [Case Report / Case Series]
Rana V (2026). [PMID: 41772076](https://pubmed.ncbi.nlm.nih.gov/41772076/). *Eye (Lond)*. [Case Report / Case Series]
Molina Martín JC (2026). [PMID: 42039976](https://pubmed.ncbi.nlm.nih.gov/42039976/). *Int J Ophthalmol*. [Basic Science / Preclinical]
Pawar N (2025). [PMID: 41102555](https://pubmed.ncbi.nlm.nih.gov/41102555/). *Eye (Lond)*. [Case Report / Case Series]
Akiyama M (2025). [PMID: 39913008](https://pubmed.ncbi.nlm.nih.gov/39913008/). *CEN Case Rep*. [Case Report / Case Series]
Sundaramurthy S (2025). [PMID: 40551348](https://pubmed.ncbi.nlm.nih.gov/40551348/). *Acta Ophthalmol*. [Epidemiology / Natural History]
Miyake Y (2025). [PMID: 40507975](https://pubmed.ncbi.nlm.nih.gov/40507975/). *Int J Mol Sci*. [Review / Meta-Analysis]
Fan F (2025). [PMID: 40668311](https://pubmed.ncbi.nlm.nih.gov/40668311/). *Int Ophthalmol*. [Review / Meta-Analysis]